DOCSLIB.ORG

Michael Givel's Curriculum Vita4c1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Michael Givel's Curriculum Vita4c1 CURRICULUM VITAE Michael Givel Department of Political Science, Dale Hall Tower, Room 224 University of Oklahoma 73019 E-mail Address: [email protected] PROFESSIONAL EDUCATION Ph.D. in Political Science: University of California, Riverside, August 1988 M.A. in Political Science: University of California, Riverside, December 1985 M.A. in Urban and Regional Planning: University of Florida, June 1980 B.A. in Political Science: University of Florida, September 1976 PROFESSIONAL EXPERIENCE July 2013 – Present: Professor: Department of Political Science, University of Oklahoma; specializing in public policy, health policy, complexity policy, Himalayan and Tibetan area studies, happiness and well-being policy, and U.S. urban politics. Current research includes examining Bhutanese diplomatic and political history including in Bhutan, India, and Tibet, happiness and well being policy, and complexity policy theory and practice. May 2018-Present: Adjunct Professor: College of International and Area Studies, University of Oklahoma; specializing in Himalayan, Bhutan, and World Happiness. July 2006-June 2013: Associate Professor: Department of Political Science, University of Oklahoma; specializing in public policy, health policy, tobacco policy, public administration, and urban politics. June 2014-August 2014: Scholar-in-Residence: Centre for Bhutan Studies, Thimphu Bhutan, researching Bhutan Gross National Happiness. December 2012-Present: Affiliate Faculty: University of Oklahoma, Department for International and Area Studies and Asian Studies Faculty. September 2014-Present: Affiliated Faculty: University of Oklahoma, Center for Social Justice July 2009-December 2009: First U.S. Fulbright to Bhutan and Visiting Professor: Departments of Management Development and Research and Consultancy, Royal Institute of Management, Semtokha: Thimphu, Bhutan; specializing in teaching and research in public administration, public policy, and tobacco policy. August 2002-July 2006: Assistant Professor: Department of Political Science, University of Oklahoma; specializing in public policy, public administration, health policy, tobacco policy, and urban politics. Michael Givel -- Curriculum Vita 2. June 1998-June 2002: Institute Project Fellow and Researcher: Institute for Health Policy Studies, School of Medicine, University of California, San Francisco; academic research and fellowship position involved with the evaluation and analysis of state and local tobacco control policy making and politics in the United States. Research analyses included examining and comparing tobacco control politics and policies and the impact of campaign contributions in Florida, Mississippi, Missouri, and California and examining the policy motivations and political tactics of the tobacco lobby as it relates to pro-tobacco and tobacco control legislation enacted in all state legislatures in the 1990s. RESEARCH INTERESTS Current Research: Policy theory, comparative public policy, Himalayan and Tibetan area studies, complexity and public policy, well being and public policy, corporate actions and policy, and public health policy. TEACHING INTERESTS Public Policy Theory Urban Policy and Theory Social Movements Comparative Public Policy Himalayan Studies BIBLIOGRAPHY Books: Givel, Michael, 1991. The War on Poverty Revisited: The Community Services Block Grant Program in the Reagan Years. Lanham, Maryland: University Press of America, an Imprint of Rowman & Littlefield Publishing Group. Givel, Michael and Andrew Spivak, 2013. Heartland Tobacco War. Lanham, Maryland: Lexington Press. Givel, Michael, 2015. The Public Policy of Gross National Happiness. Albany, New York: SUNY Press (Book Contract and in Submission) Refereed Journals: Givel, Michael, 1998. Legal Aid to the Poor: “What the National Delivery System Has and Has Not Been Doing.” St. Louis University Public Law Review. Vol. XVII (2): pp. 369 - 381. Givel, Michael and Glantz, Stanton, May 2000. “The Failure to Defend A Successful State Tobacco Control Program: Policy Lessons From Florida.” American Journal of Public Health. 90 (5): pp. 762-767. Givel, Michael and Glantz, Stanton, 2000. “Tobacco Control and Direct Democracy in Dade County, Florida: Future Implications for Health Advocates.” Journal of Public Health Policy. 21 (3): pp. 268-295. Michael Givel -- Curriculum Vita 3. Givel, Michael and Glantz, Stanton, Summer 2001. “Tobacco Lobby Political Influence on U.S. State Legislatures in the 1990s.” Tobacco Control. 10 (Summer): pp. 124-134. Givel, Michael, December 2003. “A Comparison of United States and Norwegian Regulation of Coumarin in Tobacco Products.” Tobacco Control, 12 (4): pp. 401-405. Givel, Michael and Stanton Glantz, February 2004. “The ‘Global Settlement’ With the Tobacco Industry: 6 Years Later." American Journal of Public Health. 94 (2): pp. 218-224. Pion, Martin and Givel, Michael, March 2004. “Airport Smoking Rooms Don’t Work.” Tobacco Control. 13 (Supp. 1): pp. i37-i40. Givel, Michael and Stanton Glantz, Winter 2004-5. “Political Insiders Without Grassroots Advocacy in the Administration of a Missouri Tobacco Control Youth Access Program.” Public Integrity. 7 (1): pp. 5-19. Givel, Michael, March 2005. “Oklahoma Tobacco Policy Making.” Journal of Oklahoma State Medical Association 98 (3): pp. 89-94. Givel, Michael, April 2005. “Tobacco Industry Opposition to Designating Environmental Tobacco Smoke Through E-Codes.” Journal of Public Health Policy 26 (1): pp. 75-89. Givel, Michael, December 2005. “Philip Morris’ FDA Gambit: Good for Public Health?” Journal of Public Health Policy 26 (4): pp. 450-468. Givel, Michael, January 2006. “Neoliberal and Public Health Impact of Not Adopting OSHA’s Proposed National Secondhand Tobacco Smoke Rule.” International Journal of Health Services 36 (1): pp. 137-155. Givel, Michael, 2006. “Punctuated Equilibrium in Limbo: The Tobacco Lobby and U.S. State Policy Making From 1990 to 2003.” Policy Studies Journal 43 (3): pp. 405-418. Givel, Michael, Fall 2006, "Researching State Tobacco Policymaking: Issues, Data Sources, and Methods." State Politics & Policy Quarterly. 6 (3): pp. 339-351. Givel, Michael, 2007 “Motivation of Chemical Industry Social Responsibility Through Responsible Care.” Health Policy 81 (1): pp. 85-92. Givel, Michael, 2007. “Consent and Counter-Mobilization: The Case of the National Smokers Alliance.” Journal of Health Communication 12 (4 ) pp. 339-357. Givel, Michael, 2007. “Limited State Progress in Regulating Secondhand Tobacco Smoke.” International Journal of Health Services 37 (3) pp. 469-476. Givel, Michael, 2007. "A Comparison of the Impact of U.S. and Canadian Cigarette Pack Warning Label Requirements on Tobacco Industry Profitability and the Public Health." Health Policy 83 (2-3) pp. 343-352. Givel, Michael, 2008. (Invited Publication) “Policy and Health Implications of Using the U.S. Food and Drug Administration Product Design Approach in Reducing Tobacco Product Risk.” Current Drug Abuse Reviews (1) pp. 135-141 Givel, Michael and Andrew Spivak, 2008. “Public Management and the Public Good: The Case of Oklahoma’s 2002 Secondhand Tobacco Smoke Rules.” Politics & Policy 36 (3) pp. 420-447 Michael Givel -- Curriculum Vita 4. Kelton, Max and Michael Givel, 2008. “Public Policy Implications of Tobacco Industry Smuggling Through Native American Reservations Into Canada.” International Journal of Health Services 38 (3) pp. 471- 487. Givel, Michael, 2008. “Assessing Material and Symbolic Variations in Punctuated Equilibrium and Public Policy Output Patterns.” Review of Policy Research 25 (6) pp. 547-561. Givel, Michael, 2009. "Derailing Corporate Tobacco Interests: State Initiative Policymaking from 1988 to 2006." Social Theory & Health 7 (4) pp. 339–353. Givel, Michael, 2010. “The Evolution of the Theoretical Foundations of Punctuated Equilibrium Theory in Public Policy.” Review of Policy Research 27 (2) pp. 187-198. Hearn, Bruce and Givel, Michael, 2010. “Stock Market Finance and Gross National Happiness: An Institutional Fit? Evidence from Bhutan.” Journal of Bhutan Studies 22 pp. 1-36. Givel, Michael, 2011. “In Search of the Less Risky Cigarette.” International Journal of Health Services 41 (1) pp. 77-94. Givel, Michael, 2011. “Deconstructing Social Constructionist Theory in Tobacco Policy: The Case of the Less Hazardous Cigarette.” Journal of Policy Practice 10 (1) pp. 19-34. Givel, Michael, 2011. “History of Bhutan’s Prohibition of Cigarettes: Implications for Neo-Prohibitionists and Their Critics.” International Journal of Drug Policy 22 pp. 306-310 Givel, Michael, 2011. "Tobacco Policymaking and Administration in Bhutan from 2004 to 2009." International Journal of Public Administration 34 (2) pp. 775-782 Givel, Michael and Andrew Spivak, Winter 2011-2012. “Bureaucratic Advocacy and Ethics: A State-Level Case of Public Agency Rulemaking and Tobacco Control Policy.” Public Integrity 14 (1) pp. 5-18 Givel, Michael, 2012. “Non-Punctuated and Sweeping Policy Change: Bhutan Tobacco Policymaking From 1991 to 2009. Review of Policy Research 29 (5) pp. 645-660. Givel, Michael, 2013. “Modern Neoliberal Philanthropy: Motivations and Impact of Pfizer Pharmaceutical’s Corporate Social Responsibility Campaign.” Third World Quarterly 34(1), pp. 171-182. Givel, Michael, 2013. “Campaign to Counter a Deteriorating Consumer Market: Philip Morris’s Project Sunrise.” Public Health 127 (2) pp. 134-142 Stearns, Ami, Andrew Spivak and Michael Givel, 2013. “Behind the Smokescreen: Addressing Native American Tobacco Use in Oklahoma.” International Quarterly of Community
Load more

Recommended publications
  • Electronic (E-) Cigarettes and Secondhand Aerosol
    Defending your right to breathe smokefree air since 1976 Electronic (e-) Cigarettes and Secondhand Aerosol “If you are around somebody who is using e-cigarettes, you are breathing an aerosol of exhaled nicotine, ultra-fine particles, volatile organic compounds, and other toxins,” Dr. Stanton Glantz, Director for the Center for Tobacco Control Research and Education at the University of California, San Francisco. Current Legislative Landscape As of January 2, 2014, 108 municipalities and three states include e-cigarettes as products that are prohibited from use in smokefree environments. Constituents of Secondhand Aerosol E-cigarettes do not just emit “harmless water vapor.” Secondhand e-cigarette aerosol (incorrectly called vapor by the industry) contains nicotine, ultrafine particles and low levels of toxins that are known to cause cancer. E-cigarette aerosol is made up of a high concentration of ultrafine particles, and the particle concentration is higher than in conventional tobacco cigarette smoke.1 Exposure to fine and ultrafine particles may exacerbate respiratory ailments like asthma, and constrict arteries which could trigger a heart attack.2 At least 10 chemicals identified in e-cigarette aerosol are on California’s Proposition 65 list of carcinogens and reproductive toxins, also known as the Safe Drinking Water and Toxic Enforcement Act of 1986. The compounds that have already been identified in mainstream (MS) or secondhand (SS) e-cigarette aerosol include: Acetaldehyde (MS), Benzene (SS), Cadmium (MS), Formaldehyde (MS,SS), Isoprene (SS), Lead (MS), Nickel (MS), Nicotine (MS, SS), N-Nitrosonornicotine (MS, SS), Toluene (MS, SS).3,4 E-cigarettes contain and emit propylene glycol, a chemical that is used as a base in e- cigarette solution and is one of the primary components in the aerosol emitted by e-cigarettes.
    [Show full text]
  • Web of Science® Social Sciences Citation Index® 2012 March Web of Science® - Social Sciences Citation Index Source Publications
    REUTERS/Claro Cortez IV SOURCE PUBLICATION LIST FOR WEB OF SCIENCE® SOCIAL SCIENCES CITATION INDEX® 2012 MARCH WEB OF SCIENCE® - SOCIAL SCIENCES CITATION INDEX SOURCE PUBLICATIONS TITLE ISSN E-ISSN COUNTRY PUBLISHER Abacus-A Journal of Accounting Finance and Business 0001-3072 1467-6281 AUSTRALIA WILEY-BLACKWELL Studies CONSEJO LATINOAMERICANO ESCUELAS ADM- Academia-Revista Latinoamericana de Administracion 1012-8255 COLOMBIA CLADEA ACADEMIC PSYCHIATRY 1042-9670 UNITED STATES AMER PSYCHIATRIC PUBLISHING, INC Academy of Management Annals 1941-6520 1941-6067 UNITED STATES ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD ACADEMY OF MANAGEMENT JOURNAL 0001-4273 UNITED STATES ACAD MANAGEMENT Academy of Management Learning & Education 1537-260X UNITED STATES ACAD MANAGEMENT Academy of Management Perspectives 1558-9080 UNITED STATES ACAD MANAGEMENT ACADEMY OF MANAGEMENT REVIEW 0363-7425 UNITED STATES ACAD MANAGEMENT ACCIDENT ANALYSIS AND PREVENTION 0001-4575 1879-2057 ENGLAND PERGAMON-ELSEVIER SCIENCE LTD ACCOUNTING AND BUSINESS RESEARCH 0001-4788 2159-4260 ENGLAND ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD Accounting and Finance 0810-5391 1467-629X AUSTRALIA WILEY-BLACKWELL Accounting Horizons 0888-7993 1558-7975 UNITED STATES AMER ACCOUNTING ASSOC ACCOUNTING ORGANIZATIONS AND SOCIETY 0361-3682 ENGLAND PERGAMON-ELSEVIER SCIENCE LTD ACCOUNTING REVIEW 0001-4826 UNITED STATES AMER ACCOUNTING ASSOC Across Languages and Cultures 1585-1923 1588-2519 HUNGARY AKADEMIAI KIADO RT UNIV CHILE, CENTRO INTERDISCIPLINARIO Acta Bioethica 0717-5906 1726-569X CHILE ESTUDIOS
    [Show full text]
  • Attuning the Perceptions of Peer Rating
    http://journals.sfu.ca/abr ADVANCES IN BUSINESS RESEARCH 2019, Volume 9, pages 26-45 The Rating Dilemma of Academic Management Journals: Attuning the Perceptions of Peer Rating Ahmad Rahal, Ph.D. University of Arkansas – Fort Smith Mohamed Zainuba, Ed.D University of Arkansas – Fort Smith The adoption of journal lists as proxies to scholarship quality has sparked an ongoing debate among academics over what is meant by quality, how it is perceived by the reviewers, and the thresholds for the rating, inclusion, or exclusion of journals from these lists. Given the insufficient transparencies in the processes of journal quality evaluation when composing such lists, this research explores the use of the revealed preference approach to attune the ratings in both the Australian Business Deans Council Journal Quality List and Academic Journal Guide, and approximate the rating of management journals if they were to be considered for inclusion in either of the two aforementioned lists. Keywords: ABS Guide, ABDC List, Journal Ratings, Journal Quality Guide, Journal Rankings List Introduction The worldwide emulation of the US management education system and the increased scholarship requirements by accrediting agencies has constrained the publication opportunities at top tier journals and exacerbated the proliferation of new publication outlets whose scholarship quality and credibility have not been thoroughly validated. Furthermore, the limited availability of resources, the lack of expertise, or the absence of an agreed-upon tool or mechanism to evaluate scholarship quality have prompted business schools’ administrators to adopt existing journal lists as proxies to quality (Taylor, 2011; Ozbilgin, 2009), and as the tool of choice for administrative decision making “on the ground that a journal ranking list is far more objective in its construction than the opinion of a single expert” (Sangter, 2015).
    [Show full text]
  • Tobacco Reborn: the Rise of E-Cigarettes and Regulatory Approaches
    LCB_25_3_Article_3_Aaron (Do Not Delete) 8/6/2021 9:26 AM TOBACCO REBORN: THE RISE OF E-CIGARETTES AND REGULATORY APPROACHES by Dr. Daniel G. Aaron* This Article examines e-cigarettes, FDA-regulated products which heat nico- tine-containing fluid into an aerosol to be breathed into the lungs. Recent data show that e-cigarettes are used by about one-fifth of U.S. high school students. Given that we have, in the Surgeon General’s words, reached an epidemic of youth e-cigarette use, it is worth asking how a product within FDA jurisdic- tion became a serious threat to 3.6 million youth. This Article reviews the law surrounding e-cigarettes and the history of FDA’s attempts to regulate them. Administrative law doctrines instruct us that in- creased presidential control will rein in misbehaving agencies by allowing the people to vote out a president who improperly directs the administrative state. However, e-cigarettes present a potent counterexample. On multiple occasions, presidential control over FDA stymied essential tobacco regulations by increas- ing the influence of the tobacco industry over expert agency policymaking. Yet children harmed by these tobacco policies have no right to vote and little po- litical clout with which to advocate for their interests. Ultimately, the emerg- ing approach to regulating e-cigarettes stands in opposition to a looming his- torical context and a boiling epidemic of nicotine addiction. By painting the context of e-cigarettes in lush detail, drawing from history, law, medicine, and public health, this Article charts a path forward for e-cigarettes and other ad- dicting products.
    [Show full text]
  • Open PDF File, 8.71 MB, for February 01, 2017 Appendix In
    Case 4:16-cv-00469-K Document 175 Filed 02/01/17 Page 1 of 10 PageID 5923 IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF TEXAS FORT WORTH DIVISION EXXON MOBIL CORPORATION, § § Plaintiff, § v. § No. 4:16-CV-469-K § ERIC TRADD SCHNEIDERMAN, § Attorney General of New York, in his § official capacity, and MAURA TRACY § HEALEY, Attorney General of § Massachusetts, in her official capacity, § § Defendants. § APPENDIX IN SUPPORT OF EXXON MOBIL CORPORATION’S BRIEF IN SUPPORT OF THIS COURT’S PERSONAL JURISDICTION OVER THE DEFENDANTS Exhibit Description Page(s) N/A Declaration of Justin Anderson (Feb. 1, 2017) v – ix A Transcript of the AGs United for Clean Power App. 1 –App. 21 Press Conference, held on March 29, 2016, which was prepared by counsel based on a video recording of the event. The video recording is available at http://www.ag.ny.gov/press- release/ag-schneiderman-former-vice-president- al-gore-and-coalition-attorneys-general-across B E-mail from Wendy Morgan, Chief of Public App. 22 – App. 32 Protection, Office of the Vermont Attorney General to Michael Meade, Director, Intergovernmental Affairs Bureau, Office of the New York Attorney General (Mar. 18, 2016, 6:06 PM) C Union of Concerned Scientists, Peter Frumhoff, App. 33 – App. 37 http://www.ucsusa.org/about/staff/staff/peter- frumhoff.html#.WI-OaVMrLcs (last visited Jan. 20, 2017, 2:05 PM) Case 4:16-cv-00469-K Document 175 Filed 02/01/17 Page 2 of 10 PageID 5924 Exhibit Description Page(s) D Union of Concerned Scientists, Smoke, Mirrors & App.
    [Show full text]
  • University of California San Francisco
    UNIVERSITY OF CALIFORNIA SAN FRANCISCO BERKELEY • DAVIS • IRVINE • LOS ANGELES • MERCED • RIVERSIDE • SAN DIEGO • SAN FRANCISCO SANTA BARBARA • SANTA CRUZ STANTON A. GLANTZ, PhD 530 Parnassus Suite 366 Professor of Medicine (Cardiology) San Francisco, CA 94143-1390 Truth Initiative Distinguished Professor of Tobacco Control Phone: (415) 476-3893 Director, Center for Tobacco Control Research and Education Fax: (415) 514-9345 [email protected] December 20, 2017 Tobacco Products Scientific Advisory Committee c/o Caryn Cohen Office of Science Center for Tobacco Products Food and Drug Administration Document Control Center Bldg. 71, Rm. G335 10903 New Hampshire Ave. Silver Spring, MD 20993–0002 [email protected] Re: 82 FR 27487, Docket no. FDA-2017-D-3001-3002 for Modified Risk Tobacco Product Applications: Applications for IQOS System With Marlboro Heatsticks, IQOS System With Marlboro Smooth Menthol Heatsticks, and IQOS System With Marlboro Fresh Menthol Heatsticks Submitted by Philip Morris Products S.A.; Availability Dear Committee Members: We are submitting the 10 public comments that we have submitted to the above-referenced docket on Philip Morris’s modified risk tobacco product applications (MRTPA) for IQOS. It is barely a month before the meeting and the docket on IQOS has not even closed. As someone who has served and does serve on committees similar to TPSAC, I do not see how the schedule that the FDA has established for TPSAC’s consideration of this application can permit a responsible assessment of the applications and associated public comments. I sincerely hope that you will not be pressed to make any recommendations on the IQOS applications until the applications have been finalized, the public has had a reasonable time to assess the applications, and TPSAC has had a reasonable time to digest both the completed applications and the public comments before making any recommendation to the FDA.
    [Show full text]
  • Public Health Chronicles
    Public Health Chronicles TOBACCO INDUSTRY bacco industry to manipulate information on the risks of MANIPULATION OF RESEARCH tobacco (Figure). These strategies have remained remark- ably constant since the early 1950s. During the 1950s and Lisa A. Bero, PhD 1960s, the tobacco industry focused on refuting data on the adverse effects of active smoking. The industry applied the Research findings provide the basis for estimates of risk. tools it had developed during this time to refute data on However, research findings or “facts” are subject to interpre- the adverse effects of secondhand smoke exposure from the tation and to the social construction of the evidence.1 Re- 1970s through the 1990s. search evidence has a context. The roles of framing, problem The release of previously secret internal tobacco industry definition, and choice of language influence risk communi- documents as a result of the Master Settlement Agreement cation.2 Since data do not “speak for themselves,” interest in 1998 has given the public health community insight into groups can play a critical role in creating and communicat- the tobacco industry’s motives, strategies, tactics, and data.16 ing the research evidence on risk. These documents show that for decades the industry has An interest group is an organized group with a narrowly tried to generate controversy about the health risks of its defined viewpoint, which protects its position or profits.3 products. The internal documents also reveal how the in- These groups are not exclusively business groups, but can dustry has been concerned about maintaining its credibility include all kinds of organizations that may attempt to influ- as it has manipulated research on tobacco.16 ence government.4,5 Interest groups can be expected to con- The tobacco industry has explicitly stated its goal of gen- struct the evidence about a health risk to support their erating controversy about the health risks of tobacco.
    [Show full text]
  • Health Policy Brief the State of Tobacco Use Prevention and Cessation in Ohio Environmental Scan and Policy Implications
    June 2015 Health Policy Brief The state of tobacco use prevention and cessation in Ohio Environmental scan and policy implications After releasing the Health Value Dashboard in prevalence of tobacco use given the December 2014, HPIO convened a group of strengths and challenges of Ohio’s current healthcare and public health stakeholders to tobacco policies. review Ohio’s greatest health strengths and challenges. This group identified tobacco use In addition, HPIO will soon release an as a significant concern, noting that compared accountability map that describes how various to other states, Ohio performed in the bottom public health and healthcare entities in Ohio quartile for the following metrics: are accountable for specific tobacco-related Ohio’s metrics. Metric rank Adult cigarette smoking 44 Part 1. Environmental scan Secondhand smoke exposure for children 49 The purpose of this environmental scan is to describe the current status of tobacco use in Tobacco prevention and control spending 46 Ohio, review the state-level policy landscape Tobacco use is highly relevant to state health from the 1998 Master Settlement Agreement policy because it impacts a significant number to the current session of the General Assembly, of Ohioans (approximately 2.2 million youth and and describe the extent to which Ohio is adult tobacco users1), is a major cause of illness implementing evidence-based strategies proven and premature death (see Figure 1), and results to reduce tobacco use. in lost productivity and increased healthcare Figure 1. Health consequences of costs.2 smoking and secondhand smoke Tobacco use also contributes to infant mortality Conditions causally linked to smoking and diabetes, two other health issues for which Cancers Chronic diseases Ohio ranks in the bottom quartile of states on the • Trachea, bronchus and • Diabetes Health Value Dashboard.
    [Show full text]
  • Heated Tobacco Products This Episode Is De
    Episode Details: Date of Publication: July 28, 2020 Title: Episode 18: Heated Tobacco Products Description: This episode is designed to answer all your questions about heated tobacco products, or as the industry refers to them, "heat-not-burn" products. This episode covers their design and safety, assesses their marketing and current regulation, examines a bit of the newer research and literature on the products, explains the FDA's 'modified risk' label authorization for the IQOS Heated Tobacco System, and considers policy options moving forward. Transcription: I'm Allie Rothschild and you're listening to the Counter Tobacco Podcast. You may be hearing a lot more this month than usual about heated tobacco products. That's because the Food and Drug Administration just announced a monumental decision on how one of these products, the IQOS heated tobacco system, can be marketed here in the United States. But before we dive deeper into this, I want to start at the beginning and cover some of the basics. What are heated tobacco products? Are they really safer than cigarettes? What’s all this news with the FDA? This episode is designed to answer all your questions on heated tobacco products, or HTPs. We'll look at their design and safety, assess their marketing and current regulation, examine a bit of the newer research and literature on the products, and consider policy options moving forward. So, foremost, what are and are not heated tobacco products? The most basic definition of a heated tobacco product is an electronic device that heats tobacco which produces an aerosol inhaled by the user.
    [Show full text]
  • TEA Party Exposed by ANONYMOUS Political Party
    ANONYMOUS Political Party would like to take the pleasure to introduce The TEA Party /// Tobacco Everywhere Always this DOX will serve as a wake-up call to some people in the Tea Party itself … who will find it a disturbing to know the “grassroots” movement they are so emotionally attached to, is in fact a pawn created by billionaires and large corporations with little interest in fighting for the rights of the common person, but instead using the common person to fight for their own unfettered profits. The “TEA Party” drives a wedge of division in America | It desires patriots, militias, constitutionalists, and so many more groups and individuals to ignite a revolution | to destroy the very fabric of the threads which were designed to kept this republic united | WE, will not tolerate the ideologies of this alleged political party anymore, nor, should any other individual residing in this nation. We will NOT ‘Hail Hydra”! United as One | Divided by Zero ANONYMOUS Political Party | United States of America www.anonymouspoliticalparty.org Study Confirms Tea Party Was Created by Big Tobacco and Billionaires Clearing the PR Pollution That Clouds Climate Science Select Language ▼ FOLLOW US! Mon, 2013-02-11 00:44 BRENDAN DEMELLE SUBSCRIBE TO OUR E- Study Confirms Tea Party Was Created by Big NEWSLETTER Get our Top 5 stories in your inbox Tobacco and Billionaires weekly. A new academic study confirms that front 12k groups with longstanding ties to the tobacco industry and the billionaire Koch Like DESMOG TIP JAR brothers planned the formation of the Tea Help us clear the PR pollution that Party movement more than a decade clouds climate science.
    [Show full text]
  • The Tobacco Industry's Successful Efforts to Control Tobacco Policy
    The Tobacco Industry’s Successful Efforts to Control Tobacco Policy Making in Switzerland Chung-Yol Lee, MD MPH Stanton A. Glantz, PhD Division of Adolescent Medicine Department of Pediatrics Institute for Health Policy Studies School of Medicine University of California, San Francisco San Francisco CA 94143 January 2001 The Tobacco Industry’s Successful Efforts to Control Tobacco Policy Making in Switzerland Chung-Yol Lee, MD MPH Stanton A. Glantz, PhD Division of Adolescent Medicine Department of Pediatrics Institute for Health Policy Studies School of Medicine University of California, San Francisco San Francisco CA 94143 January 2001 Supported in part by Swiss National Science Foundation Grant 823B-053423 to the first author and National Cancer Institute Grants CA-61021 and CA-87482, American Cancer Society Grant CCG-294, and a grant from the Richard and Rhoda Goldman Fund to the second author. This report was prepared in response to a request from the World Health Organization Tobacco Free Initiative. Opinions expressed reflect the views of the authors and do not necessarily represent any sponsoring agency, the WHO, or the Division of Adolescent Medicine or the Institute for Health Policy Studies at the University of California. Copyright 2000 by Chung-Yol Lee and Stanton Glantz. This report is available on the World Wide Web at http://www.library.ucsf.edu/tobacco/swiss. (5/28/01 correction) This report is the latest in a series of reports that analyze tobacco industry campaign contributions, lobbying, and other political activity. The previous reports are: M. Begay and S. Glantz. Political Expenditures by the Tobacco Industry in California State Politics UCSF IHPS Monograph Series, 1991.
    [Show full text]
  • Stanton A. Glantz Papers MSS.97.08
    http://oac.cdlib.org/findaid/ark:/13030/c8wq086t No online items Stanton A. Glantz Papers MSS.97.08 David Krah University of California, San Francisco Archives & Special Collections 530 Parnassus Ave Room 524 San Francisco, CA 94143-0840 415-476-8112 [email protected] URL: http://www.library.ucsf.edu/collections/archives Stanton A. Glantz Papers MSS.97.08 1 MSS.97.08 Language of Material: English Contributing Institution: University of California, San Francisco Archives & Special Collections Title: Stanton A. Glantz Papers creator: Glantz, Stanton A. Identifier/Call Number: MSS.97.08 Physical Description: 12.5 Linear Feet(7 cartons, 12 boxes) Date (inclusive): 1983-2012 Biographical note Stanton Arnold Glantz is a professor in the Department of Medicine, School of Medicine, at the University of California, San Francisco, and a well-known anti-tobacco activist and writer. In 1994, Glantz donated to the UCSF Tobacco Control Archives his research files based on copies of internal tobacco industry documents, which are known as the Brown & Williamson Collection. He co-authored with John Slade, Lisa A. Bero, Peter Hanauer, and Deborah E. Barnes The Cigarette Papers (Berkeley: University of California Press, c1996) and Tobacco War: Inside the California Battles (Berkeley: University of California Press, c.2000) with Edith D. Balbach. Glantz has written numerous articles based on the Brown & Williamson industry documents and co-wrote a series of reports on the tobacco industry and anti-tobacco activities around the country. Glantz received a Ph.D. in Applied Mechanics/Engineering-Economic Systems from Stanford University in 1973 and stayed at Stanford as a Research Fellow in Cardiology.
    [Show full text]